OCGN

NASDAQ · Biotechnology

Ocugen Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$0.93

+0.11 (+13.29%)

As of Nov 8, 10:31 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +3,140.0% upside

Low Target $22.68

Average Target $29.97

High Target $39.58

Current Price $0.93

Current
$0.93

Target
$29.97

$22.68 $29.97 avg $39.58

Scenario Analysis

Bear Case

$22.68

2,351.9%

Low target

Base Case

$29.97

+3,140.0%

Avg target

Bull Case

$39.58

+4,178.9%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$2.73

-66.1% from high

52-Week Low

$0.69

+33.9% from low

Target vs 52W High

$29.97

+999.8% vs high

Next Earnings Report

Nov 10, 2026

tomorrow

EPS Est: $-0.06

Earnings in 1 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	32%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-40.7%